Current treatment of atypical mycobacteriosis

Author： Esteban Jaime   Ortiz-Pérez Alberto  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2787-2799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current treatment of nontuberculous mycobacteriosis: an update

By Esteban Jaime   García-Pedrazuela María   Muñoz-Egea María Carmen   Alcaide Fernando  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 967-986

Informa Healthcare

Access to resources Recommend Favorite

Atypical antipsychotics in the treatment of bipolar disorder

By Strakowski Stephen M   Del Bello Melissa P   Adler Caleb M   Keck Jr Paul E  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 751-760

Informa Healthcare

Access to resources Recommend Favorite

Natalizumab: Mycobacteriosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Advantages of atypical antipsychotics in the maintenance treatment of schizophrenia

By Kissling W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

The Role of Atypical Antipsychotics in the Treatment of Movement Disorders

By Fernandez H.H.   Friedman J.H.  

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 467-483

Adis International

Access to resources Recommend Favorite